The work showed that this docking at the level of B16 melanoma cells could trigger the NF-kappaB signalling pathway, the activation of which not only promoted cell proliferation but also increased resistance to apoptosis through the up-regulation of factors such as Bcl-2 and Bcl-xL and the down-regulation of Bax. This evidence concerns the gene BCL2L1 and melanoma.